Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson's disease.

Wang, Ai-Qin; Kong, Li-Na; Meng, Ming-Zhu; Zhao, Xiu-He; Chen, Si; Wang, Xiao-Tang

Wang, Ai-Qin; Kong, Li-Na; Meng, Ming-Zhu; Zhao, Xiu-He; Chen, Si; Wang, Xiao-Tang.

Afiliação

Wang AQ; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Kong LN; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Meng MZ; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Zhao XH; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Chen S; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Wang XT; Qilu Hospital of Shandong University, Jinan, Shandong Province, China.

Neural Regen Res ; 14(8): 1438-1444, 2019 Aug.

Article em En | MEDLINE | ID: mdl-30964070

Palavras-chave

2; 3; 6-tetrahydropyridine; fibroblast growth factor 20; A-type potassium current; long-term potentiation; Kv4.2; oxidative stress; malondialdehyde; motor performance; neural regeneration; nerve regeneration; Parkinson's disease; 1-methyl-4-phenyl-1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article